Enterprise

Tianjin Cansino Biological Vaccine Production Base Phase 1

                       
Update time:27 Sep, 2021
Project Introduction:

The Phase 1 project of Cansino Biological Vaccine Production Base is located to the west of Chunhua Road, West District of Tianjin Economic and Technological Development Zone, with a construction area of 37,000 square meters and a designed production capacity of 70 million doses. It is expected to become a human vaccine production base with great industrial conversion value in China.
The project mainly includes: new vaccine production workshop, animal laboratory building, raw material and finished product warehouse, power center, sewage treatment station and other related supporting facilities that meet the standards of China and the World Health Organization. Among them, a number of high-end biological vaccine products such as recombinant Ebola vaccine, meningitis conjugate vaccine, DTP combined vaccine, pneumonia conjugate vaccine and other high-end biological vaccine products will be produced here. This project has a total of 8000 six types of unshielded information points.